CIK 0001434647 · Non-accelerated filer<br>Smaller reporting company
ZEVRA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ZVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205894398
- Phone
- (888) 958-1253
- Business address
- 101 FEDERAL STREET, BOSTON, MA, 02110
- Former names
- KEMPHARM, INC, KEMPHARM INC
- PRER14A Other PRER14A
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- DFAN14A Other Proxy Soliciting Materials
- PREN14A Other PREN14A
- DEFA14A Proxy Proxy Materials
- 8-K Event Regulation FD disclosure
- PREC14A Other PREC14A
- 8-K Event Bylaws or fiscal year change
- 8-K Event Results of operations
- 8-K Event Other events
- 4 Open-market buy CFO, Secretary & Treasurer bought 635 shares at an average $5.81 ($3,690)
- 4 Open-market buy Chief Executive Officer bought 9,500 shares at $5.44 ($51,679)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
Page 15 of 44 · 870 filings